FDAFDA · Food and drugs·Recall number D-0006-2017
Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc., Lexington, MA 02421, NDC 59417-103-10
Published October 12, 2016 · Recall initiated: September 2, 2016
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablets/Capsules
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- VYVANSE
- Manufacturer
- Shire
- Distributor
- Nationwide
- Lot
- Lot # AF3360B; Exp. 04/19
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.